Table 3 Odds ratios and 95% CrIs for mixed treatment comparisons of confirmed infection studies, all-cause mortality
From: Antifungal treatment for invasive Candida infections: a mixed treatment comparison meta-analysis
Treatment Comparison | Odds Ratio | 95% Credible Interval |
|---|---|---|
Caspofungin vs. Fluconazole | 1.34 | (0.65, 2.48) |
Amphotericin B Deoxycholate vs. Fluconazole | 1.14 | (0.78, 1.62) |
Amphotericin B Liposomal vs. Fluconazole | 1.81 | (0.71, 3.90) |
Voriconazole vs. Fluconazole | 0.90 | (0.48, 1.53) |
Micafungin vs. Fluconazole | 1.73 | (0.74, 3.49) |
Anidulafungin vs. Fluconazole | 0.67 | (0.36, 1.14) |
Itraconazole vs. Fluconazole | 0.83 | (0.11, 2.94) |
Amphotericin B Deoxycholate vs. Caspofungin | 0.92 | (0.50, 1.54) |
Amphotericin B Liposomal vs. Caspofungin | 1.35 | (0.77, 2.20) |
Voriconazole vs. Caspofungin | 0.72 | (0.33, 1.38) |
Micafungin vs. Caspofungin | 1.28 | (0.86, 1.85) |
Anidulafungin vs. Caspofungin | 0.56 | (0.21, 1.22) |
Itraconazole vs. Caspofungin | 0.67 | (0.08, 2.44) |
Amphotericin B Liposomal vs. Amphotericin B Deoxycholate | 1.58 | (0.68, 3.17) |
Voriconazole vs. Amphotericin B Deoxycholate | 0.78 | (0.49, 1.19) |
Micafungin vs. Amphotericin B Deoxycholate | 1.51 | (0.72, 2.81) |
Anidulafungin vs. Amphotericin B Deoxycholate | 0.60 | (0.29, 1.12) |
Itraconazole vs. Amphotericin B Deoxycholate | 0.72 | (0.10, 2.50) |
Voriconazole vs. Amphotericin B Liposomal | 0.57 | (0.21, 1.26) |
Micafungin vs. Amphotericin B Liposomal | 0.98 | (0.67, 1.38) |
Anidulafungin vs. Amphotericin B Liposomal | 0.44 | (0.13, 1.08) |
Itraconazole vs. Amphotericin B Liposomal | 0.53 | (0.06, 2.02) |
Micafungin vs. Voriconazole | 2.02 | (0.82, 4.18) |
Anidulafungin vs. Voriconazole | 0.81 | (0.33, 1.68) |
Itraconazole vs. Voriconazole | 0.97 | (0.12, 3.46) |
Anidulafungin vs. Micafungin | 0.45 | (0.15, 1.05) |
Itraconazole vs. Micafungin | 0.54 | (0.06, 2.02) |
Itraconazole vs. Anidulafungin | 1.34 | (0.15, 5.05) |